Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • BioCell UPF
    Junior Member
    • Mar 2018
    • 1

    Bioinformatician / Big Data Analyst, UPF

    Pompeu Fabra University (UPF), PRBB, Barcelona
    Cell Biology Group


    Bioinformatician / Big Data Analyst

    We are recruiting a Bioinformatician / NGS (Next Generation Sequencing) Data Analyst who will join our research team, the Cell Biology Group (www.upf.edu/cellbiology), at the Department of Experimental and Health Sciences of the Pompeu Fabra University (UPF) in Barcelona. We investigate the mechanisms underlying the loss of stem cell regenerative decline with aging, by combining genome-wide experiments and cutting-edge genetic, molecular and biochemical assays.

    You will be employed on the ERC Advanced Grant ‘Stem-Aging' and be part of a dedicated team of molecular and cell biologists. You will actively participate in projects that combine molecular biology, transcriptomics, epigenetics and bioinformatics, mouse genetics and tissue injury-regeneration, as well as proteostasis and senescence approaches, to define the intricate regulatory circuitry of stem cell aging, and potential rejuvenating strategies.
    We are looking for a highly motivated individual who works closely together with wet lab scientists. The tasks include analysis, interpretation and integration of comprehensive, state-of-the-art genome-wide datasets such as RNA-seq, ATAC-seq and ChIP-seq, as well as transcription factor motif analysis, pathway analysis and development and implementation of analysis pipelines. Applicants are expected to hold an academic degree (BSc, MSc, PhD in Bioinformatics, Biostatistics, or Life Sciences) and be proficient in NGS data analysis (e.g. transcriptome profiling data sets), including scripting, programming, statistical analyses and applying common standard analysis tools and algorithms (R/Bioconductor, python, etc). Experience in epigenetic mechanisms of gene regulation and analysis of circadian rhythms is welcome.

    Candidates are expected to be fluent in English, have excellent communication- and inter-personal skills and be highly motivated to become an integral part of a driven and dynamic multi-disciplinary team. Strong applicants should show critical and independent thinking.

    We offer a dynamic and international working environment at the Department of Experimental and Health Sciences (UPF), located at the Barcelona Biomedical Research Park (PRBB), a world-class research institute offering a vibrant community of international researchers and state-of-the-art facilities.

    Application: CV, list of publications and contact information for referees should be sent to: [email protected]

    Recent publications from the lab
    • Solanas G, Peixoto FO, Perdiguero E, Jardí M, Ruiz-Bonilla V, Datta D, Symeonidi A, Castellanos A, Welz PS, Caballero JM, Sassone-Corsi P, Muñoz-Cánoves P*, Benitah SA*. Aged Stem Cells Reprogram Their Daily Rhythmic Functions to Adapt to Stress. Cell 170:678-692, 2017
    • Proteostatic and Metabolic Control of Stemness. García-Prat L, Sousa-Victor P, Muñoz-Cánoves P. Cell Stem Cell 20:593-608 (2017)
    • Autophagy maintains stemness by preventing senescence. García-Prat L, Martínez-Vicente M, Perdiguero E, Ortet L, Rodríguez-Ubreva J, Rebollo E, Ruiz-Bonilla V, Gutarra S, Ballestar E, Serrano AL, Sandri M, Muñoz-Cánoves P. Nature 529:37-42 (2016)
    • Geriatric muscle stem cells switch reversible quiescence into senescence. Sousa-Victor P, Gutarra S, García-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V, Jardí M, Ballestar E, González S, Serrano AL, Perdiguero E, Muñoz-Cánoves P. Nature 506:316-21 (2014)

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 11:41 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Working...